This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

W. Allen Hauser, MD

Arch Neurol. 1986;43(12):1287-1288.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The occurrence of a seizure is a frightening event, both for the individual affected and for those who witness the episode. If medical attention is sought, the clinician must determine both the potential underlying or precipitating cause of the event and decide what therapeutic intervention, if any, is warranted. In general, the latter decision is based on the former determination.

In situations in which a clearly remediable cause of seizures is identified, the need for short- or long-term therapy with anticonvulsant drugs (ACDs) may be less important than the need for timely intervention to remedy the primary problem. When no potentially remediable metabolic or structural abnormality is identified, the clinician is still faced with a decision of whether to recommend short- or long-term ACD therapy. It should be clear that the potential for benefit of the therapy should exceed the risk associated with initiation of the therapy. Thus, the frequency . . . [Full Text PDF of this Article]

Author Affiliations
From the G. H. Sergievsky Center, New York.

Footnotes
Accepted for publication July 26, 1986.

Reprint requests to G. H. Sergievsky Center, 630 168th St, New York, NY 10032 (Dr Hauser).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?